All Stories

  1. Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy
  2. Altered proteasome function in right ventricular hypertrophy
  3. Early injury of the neonatal lung contributes to premature lung aging: a hypothesis
  4. Proteasome function shapes innate and adaptive immune responses
  5. Proteasome function in lung disease
  6. Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes
  7. Lung cancer nanomedicine: potentials and pitfalls
  8. Regulation of 26S Proteasome Activity in Pulmonary Fibrosis
  9. Proteasome function is not impaired in healthy aging of the lung
  10. Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
  11. LSC Abstract – Cigarette smoke impairs proteasome-dependent MHC I antigen presentation
  12. Validated prediction of pro-invasive growth factors using a transcriptome-wide invasion signature derived from a complex 3D invasion assay
  13. Regulation of Immunoproteasome Function in the Lung
  14. Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to ex Vivo Human and Mouse Lung Tumors
  15. Hallmarks of the ageing lung
  16. Blue Journal Conference. Aging and Susceptibility to Lung Disease
  17. Regulation of the Proteasome: Evaluating the Lung Proteasome as a New Therapeutic Target
  18. Proteostasis in pediatric pulmonary pathology
  19. Efficient Bioactive Delivery of Aerosolized Drugs to Human Pulmonary Epithelial Cells Cultured in Air–Liquid Interface Conditions
  20. Critical role of interleukin 1 for the initiation and resolution of pulmonary inflammation induced by carbon nanomaterials
  21. Cigarette Smoke–Induced Disruption of Bronchial Epithelial Tight Junctions Is Prevented by Transforming Growth Factor-β
  22. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery
  23. Protein Quality Control Coming of Age
  24. Molecular Aspects of Aging
  25. Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors
  26. Low Dose Proteasome Inhibition Affects Alternative Splicing
  27. Acute Effect Of Cigarette Smoke On Proteasome Function
  28. What shall we do with the damaged proteins in lung disease? Ask the proteasome!
  29. Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease
  30. Characterization Of The Proteasome In Normal And COPD Diseased Lungs
  31. Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells
  32. Proteasome inhibition prevents experimentally-induced endothelial dysfunction
  33. Comprehensive proteomic and transcriptomic analysis reveals early induction of a protective anti-oxidative stress response by low-dose proteasome inhibition
  34. Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system
  35. ChemInform Abstract: Proteasome Inhibitors: Poisons and Remedies
  36. Markers of instability in high-risk carotid plaques are reduced by statins
  37. Proteasome inhibitors: Poisons and remedies
  38. Role of HGF/SF and c-Met in Morphogenesis and Metastasis of Epithelial Cells
  39. Screening of the Dose-Dependent Effects of Proteasome Inhibition by a Proteomic and Transcriptomic Approach
  40. Low-dose renin inhibitor and low-dose AT1-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes
  41. Nontoxic proteasome inhibition activates a protective antioxidant defense response in endothelial cells
  42. Ongoing Coxsackievirus Myocarditis Is Associated with Increased Formation and Activity of Myocardial Immunoproteasomes
  43. Inhibition of the Ubiquitin-Proteasome System Protects Endothelial Cells from Oxidative Stress
  44. Proteasome inhibitors induce antioxidative enzymes and confer cardioprotection against oxidative stress
  45. Effect of statins on the proteasomal activity in mammalian endothelial and vascular smooth muscle cells
  46. Cardiac gene expression profile in rats with terminal heart failure and cachexia
  47. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells
  48. Inhibition of chemokine production from human airway smooth muscle cells by fluticasone, budesonide and beclomethasone
  49. Inhibition of the Ubiquitin-Proteasome Pathway Induces Differential Heat-Shock Protein Response in Cardiomyocytes and Renders Early Cardiac Protection
  50. Role of morphogenetic factors in metastasis of mammary carcinoma cells